Literature DB >> 27017521

Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation.

Min Zhang1, Liang Li1, Wei Xie1, Jian-Feng Wu2, Feng Yao1, Yu-Lin Tan1, Xiao-Dan Xia1, Xiao-Yan Liu1, Dan Liu1, Gang Lan1, Meng-Ya Zeng1, Duo Gong1, Hai-Peng Cheng1, Chong Huang1, Zhen-Wang Zhao1, Xi-Long Zheng3, Chao-Ke Tang4.   

Abstract

RATIONALE: Previous studies have shown that apolipoprotein-1 (apoA-1) binding protein (AIBP) is highly associated with the regulation of apoA-1 metabolism, suggesting its role in the treatment of atherosclerosis. However, how AIBP regulates foam cell formation remains largely unexplored.
OBJECTIVE: To investigate the mechanisms underlying AIBP inhibition of foam cell formation from macrophages. METHODS AND
RESULTS: THP-1-derived macrophages were incubated without or with apoA-1 and AIBP, followed by assessing the formation of foam cells and the potential mechanisms. Our results showed that AIBP and apoA-1 enhanced cholesterol efflux, altered the levels of cellular free cholesterol and cholesterol ester and prevented lipid accumulation so as to reduce the formation of foam cells. Meanwhile, lack of AIBP 115-123 amino acids resulted in the loss of AIBP binding to apoA-1. Moreover, our chemiluminescent analysis showed that AIBP promoted biotin-labeled apoA-1 binding to macrophages. Besides with AIBP, more apoA-1 bound to ABCA1, a key transporter responsible for cholesterol efflux to apoA-1, as indicated by our co-immunoprecipitation assay. Our results also showed that AIBP did not regulate ABCA1 mRNA expression, but stabilized its protein from CSN2-mediated degradation.
CONCLUSIONS: AIBP promotes apoA-1 binding to ABCA1 on the cell membrane of macrophages and prevents ABCA1 protein from CSN2-mediated degradation so as to prevent foam cell formation. AIBP 115-123 amino acids is at least partially responsible for its binding to apoA-1.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ABCA1; AIBP; ApoA-1; Atherosclerosis; CSN2; Cholesterol efflux; Foam cell; Ubiquitination

Mesh:

Substances:

Year:  2016        PMID: 27017521     DOI: 10.1016/j.atherosclerosis.2016.03.008

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  Inhibition of Neuroinflammation by AIBP: Spinal Effects upon Facilitated Pain States.

Authors:  Sarah A Woller; Soo-Ho Choi; Eun Jung An; Hann Low; Dina A Schneider; Roshni Ramachandran; Jungsu Kim; Yun Soo Bae; Dmitri Sviridov; Maripat Corr; Tony L Yaksh; Yury I Miller
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

2.  AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.

Authors:  Soo-Ho Choi; Aaron M Wallace; Dina A Schneider; Elianne Burg; Jungsu Kim; Elena Alekseeva; Niki Dj Ubags; Carlyne D Cool; Longhou Fang; Benjamin T Suratt; Yury I Miller
Journal:  JCI Insight       Date:  2018-08-23

Review 3.  Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases.

Authors:  Pooranee K Morgan; Longhou Fang; Graeme I Lancaster; Andrew J Murphy
Journal:  J Lipid Res       Date:  2019-08-30       Impact factor: 5.922

4.  AIBP, inflammation, and atherosclerosis.

Authors:  Hainan Chen; Kai Yin
Journal:  J Lipid Res       Date:  2018-05-04       Impact factor: 5.922

5.  AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling.

Authors:  Renfang Mao; Shu Meng; Qilin Gu; Raquel Araujo-Gutierrez; Sandeep Kumar; Qing Yan; Felicidad Almazan; Keith A Youker; Yingbin Fu; Henry J Pownall; John P Cooke; Yury I Miller; Longhou Fang
Journal:  Circ Res       Date:  2017-03-21       Impact factor: 17.367

Review 6.  Regulation of lipid rafts, angiogenesis and inflammation by AIBP.

Authors:  Longhou Fang; Yury I Miller
Journal:  Curr Opin Lipidol       Date:  2019-06       Impact factor: 4.776

7.  ATP-binding cassette transporter A1: A promising therapy target for prostate cancer.

Authors:  Ting Xiong; Gang Xu; Xue-Long Huang; Kai-Qiang Lu; Wei-Quan Xie; Kai Yin; Jian Tu
Journal:  Mol Clin Oncol       Date:  2017-11-15

8.  AIBP protects against metabolic abnormalities and atherosclerosis.

Authors:  Dina A Schneider; Soo-Ho Choi; Colin Agatisa-Boyle; Laurence Zhu; Jungsu Kim; Jennifer Pattison; Dorothy D Sears; Philip L S M Gordts; Longhou Fang; Yury I Miller
Journal:  J Lipid Res       Date:  2018-03-20       Impact factor: 5.922

Review 9.  Lipid rafts as a therapeutic target.

Authors:  Dmitri Sviridov; Nigora Mukhamedova; Yury I Miller
Journal:  J Lipid Res       Date:  2020-03-23       Impact factor: 5.922

10.  Maternal hypercholesterolemia enhances oxysterol concentration in mothers and newly weaned offspring but is attenuated by maternal phytosterol supplementation.

Authors:  Jerad H Dumolt; Sandhya K Radhakrishnan; Mohammed H Moghadasian; Khuong Le; Mulchand S Patel; Richard W Browne; Todd C Rideout
Journal:  J Nutr Biochem       Date:  2017-09-28       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.